Researchers in Japan said on Wednesday they have succeeded in growing human kidney tissue from stem cells for the first time in a potential breakthrough for millions with damaged organs who are dependent on dialysis.
Kidneys have a complex structure that is not easily repaired once damaged, but the latest findings put scientists on the road to helping a diseased or distressed organ fix itself.
Kenji Osafune of Kyoto University said his team had managed to take stem cells — the “blank slates” capable of being programmed to become any kind of cell in the body — and nudge them specifically
All over the world there are desperate patients looking for institutions that promise to heal them with stem cells. But the treatments that are promised must be controlled and regulated, said two scholars in Science magazine. Today, recognized treatments with stem cells involve blood diseases or immune system defects, wrote the Thai researcher Sorapop Kiatpongsan and his Japanese colleague Douglas Sipp. In reality, many other treatments have been offered without proof of their effectiveness.
For example, treatments are being offered to cure heart disease, autism, Down’s syndrome, and epilepsy. These treatments are ineffective and are mainly
Osteoarthritis is a very common joint disorder. Due to age and normal wear and tear on the joints, the cartilage that protects the joint begins to break down, causing the bone to rub together which leads to pain and swelling in the joints. There is no cure for osteoarthritis, and up until now, many patients feel that surgery is their only option to manage the symptoms.
However, recently orthopaedic investigators have been studying the effects of periodic injections to the knee of stem cells from synovium, a thin membrane covering the inside of the joint. Nobutake Ozeki from Tokyo Medical
Stem Cell Research Provides Help for Breast Reconstruction
Irene MacKenzie had a lumpectomy for her early stage breast cancer leaving her with a hollow in her breast. The lumpectomy took care of the cancer, but what about her breast? Well, Irene was the first person in Britain to reap the benefits of Stem Cell […]
Cellular Dynamics International, Inc. (CDI), the world’s largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, today announced the launch of its MyCell™ Services. These services include novel iPS cell line reprogramming, genetic engineering and differentiation of iPS cells into commercially available iCell® terminal tissue cells (for example, heart or nerve cells).
“CDI’s mission is to be the top developer and manufacturer of standardized human cells in high quantity, quality and purity and to make these cells widely available to the research community. Our MyCell Services provide researchers with unprecedented access to the full diversity